94 related articles for article (PubMed ID: 25371324)
1. Overexpression of adenylate cyclase-associated protein 1 may predict brain metastasis in non-small cell lung cancer.
Xie SS; Tan M; Lin HY; Xu L; Shen CX; Yuan Q; Song XL; Wang CH
Oncol Rep; 2015 Jan; 33(1):363-71. PubMed ID: 25371324
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma.
Liu Y; Cui X; Hu B; Lu C; Huang X; Cai J; He S; Lv L; Cong X; Liu G; Zhang Y; Ni R
Pathol Res Pract; 2014 Mar; 210(3):169-75. PubMed ID: 24359721
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
5. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
6. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
8. Relationship of intracellular proteolysis with CAP1 and cofilin1 in non-small-cell lung cancer.
Kolegova ES; Kakurina GV; Shashova EE; Yunusova NV; Spirina LV; Sidenko EA; Kostromitskiy DN; Dobrodeev AY; Kondakova IV
J Biosci; 2021; 46():. PubMed ID: 34148878
[TBL] [Abstract][Full Text] [Related]
9. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of ezrin in non--small-cell lung cancer.
Zhang XQ; Chen GP; Wu T; Yan JP; Zhou JY
Clin Lung Cancer; 2012 May; 13(3):196-204. PubMed ID: 22137559
[TBL] [Abstract][Full Text] [Related]
11. Adenylate Cyclase-Associated Protein 1 and Cofilin in Progression of Non-Small Cell Lung Cancer.
Kolegova ES; Kakurina GV; Kondakova IV; Dobrodeev AY; Kostromitskii DN; Zhuikova LD
Bull Exp Biol Med; 2019 Jul; 167(3):393-395. PubMed ID: 31346877
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases.
Paratore S; Banna GL; D'Arrigo M; Saita S; Iemmolo R; Lucenti L; Bellia D; Lipari H; Buscarino C; Cunsolo R; Cavallaro S
Cancer Biomark; 2011-2012; 10(2):79-89. PubMed ID: 22430135
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
14. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
15. [Robo1 expression in non-small cell lung cancer and its brain metastasis].
Li XX; Jin L; Sun ZF; Gu F; Li WL; Ma YJ
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):198-201. PubMed ID: 23880000
[TBL] [Abstract][Full Text] [Related]
16. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion.
Zeng J; Li X; Liang L; Duan H; Xie S; Wang C
J Cancer Res Clin Oncol; 2022 Jan; 148(1):137-153. PubMed ID: 34636991
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
20. High expression of Cullin1 indicates poor prognosis for NSCLC patients.
Xu M; Yang X; Zhao J; Zhang J; Zhang S; Huang H; Liu Y; Liu J
Pathol Res Pract; 2014 Jul; 210(7):397-401. PubMed ID: 24767980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]